Company · CIK 0001668243 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
UroGen Pharma Ltd. · URGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 871 | $42.92 | $37,383 | 59,882 | −1.43% | |
| Sep 8, 2026 SForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 1,519 | $42.54 | $64,618 | 53,141 | −2.78% | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 1,667 | — | — | 60,753 | — | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 3,334 | — | — | 54,660 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2026 MForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 1,667 | — | — | 0 | — | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 3,334 | — | — | 0 | — |